Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

What Is the Outlook for Futu Shares?

Futu shares rose 7.1% this afternoon to a price of $193.19. The stock is still trading within range of its average target price of $192.08, and over the last 52 weeks, it has recorded a 186.8% performance. Analysts have given the Large-Cap Capital Markets stock target prices ranging from $133.55344 to $231.93861 dollars per share, with an average rating of buy.

The stock has an above average percentage of its shares sold short at 8.7%, and a short ratio of 1.92. The company's insiders own 15.94% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that only a small number of institutional investors are invested in the stock, with 43.5% of Futu's shares being owned by this investor type.

Institutions Invested in Futu

Date Reported Holder Percentage Shares Value
2025-06-30 HHLR Advisors, LTD 5% 4,312,237 $833,059,494
2025-06-30 Blackrock Inc. 4% 3,814,270 $736,859,740
2025-06-30 Aspex Management (HK) Ltd 4% 3,393,307 $655,536,004
2025-06-30 Price (T.Rowe) Associates Inc 2% 1,784,835 $344,803,345
2025-06-30 Arrowstreet Capital, Limited Partnership 2% 1,544,025 $298,282,465
2025-06-30 Greenwoods Asset Management Hong Kong Ltd. 2% 1,531,389 $295,841,380
2025-06-30 Morgan Stanley 1% 1,272,026 $245,736,339
2025-06-30 State Street Corporation 1% 1,212,481 $234,233,139
2025-06-30 HSG Holding Ltd 1% 1,057,644 $204,320,953
2025-06-30 Goldman Sachs Group Inc 1% 1,056,887 $204,174,712

Besides an analyst consensus of little upside potential, other market factors point to there being mixed market sentiment on Futu.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS